The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar

C P Sinha et al. J Assoc Physicians India. 1978 May.

. 1978 May;26(5):353-60.

No abstract available

Similar articles

Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP, Pande JN, Khilnani GC, Kailash S. Singh SP, et al. Indian J Chest Dis Allied Sci. 1996 Jan-Mar;38(1):5-11. Indian J Chest Dis Allied Sci. 1996. PMID: 16892742
[Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
Powłowska I, Rakowska Z. Powłowska I, et al. Pneumonol Pol. 1978 Aug;46(8):605-12. Pneumonol Pol. 1978. PMID: 714703 Polish. No abstract available.
[Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].
Pilheu JA, De Salvo MC, Manchinu I, de Negroni NR, Szemzo J. Pilheu JA, et al. Medicina (B Aires). 1980 Jul-Aug;40(4):382-6. Medicina (B Aires). 1980. PMID: 7207170 Spanish. No abstract available.
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
Ellard GA. Ellard GA. Tubercle. 1984 Sep;65(3):211-27. doi: 10.1016/0041-3879(84)90079-5. Tubercle. 1984. PMID: 6385429 Review. No abstract available.
[Clinical pharmacology of isoniazid (a review of the literature)].
Ivleva AIa. Ivleva AIa. Probl Tuberk. 1979 Jan;(1):18-26. Probl Tuberk. 1979. PMID: 368763 Review. Russian. No abstract available.